Pricing Log in Create free account
Saturday 17 October 2026 Export AMPH’s income statement to Excel — free account

Amphastar Pharmaceuticals, Inc.

AMPH Healthcare Drug Manufacturers Specialty & Generic

Amphastar Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $719.9 million, down 1.65% from fiscal 2024. In the quarter to June 2026, revenue grew 5.44%, EPS grew 4.55%, free cash flow grew 87.6% and total debt was flat, each against the same quarter a year earlier.

25.87 0.55 −2.08%
Market cap
$1.1B
P/E
14.9×
Fwd P/E
14.7×
Dividend yield
—
F-score
6/9
Altman Z
2.54
Beneish M
−2.57
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Amphastar Pharmaceuticals, Inc. (AMPH) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Amphastar Pharmaceuticals, Inc. (AMPH) trades at a P/E ratio of 14.9×. Over the past ten years it has ranged from 0.0× (March 2019) to 9,405× (December 2017); the current reading is higher than 41% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 19.2× and below the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 12.8× 13.00%
FY2024 11.3× (48.54%)
FY2023 21.9× 45.44%
FY2022 15.1× (15.83%)
FY2021 17.9× (96.44%)
FY2020 503× 2,610.52%
FY2019 18.5× —
FY2018 0.0× —
FY2017 250× 223.82%
FY2016 77.1× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 11.6× 1.24%
Mar 2026 11.5× (10.17%)
Dec 2025 12.8× 12.93%
Sep 2025 11.3× 38.20%
42 more quarters

Against its own ten years

Low 0.0× High 9,405×
Ten-year median 17.9×
Current reading's percentile 27

P/E ratio against peers

Company P/E ratio
XERS Xeris Biopharma Holdings, Inc. compare n/m
HROW Harrow, Inc. compare n/m
AMPH Amphastar Pharmaceuticals, Inc. 14.9×
ANIP ANI Pharmaceuticals, Inc. compare 14.9×
COLL Collegium Pharmaceutical, Inc. compare 15.2×
PAHC Phibro Animal Health Corporation compare 15.8×
CRON Cronos Group Inc. compare 16.1×
PCRX Pacira BioSciences, Inc. compare 104×
ETON Eton Pharmaceuticals, Inc. compare 107×
Drug Manufacturers Specialty & Generic industry median 19.2×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on AMPH